{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:31:57Z","timestamp":1778571117374,"version":"3.51.4"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082330","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T23:05:47Z","timestamp":1385507147000},"page":"e82330","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Combined Adenovirus-Mediated Artificial microRNAs Targeting mfgl2, mFas, and mTNFR1 Protect against Fulminant Hepatic Failure in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Dong","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huali","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B virus infection","volume":"337","author":"WM Lee","year":"1997","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/gast.2002.33428","article-title":"Molecular diagnosis of viral hepatitis","volume":"122","author":"JM Pawlotsky","year":"2002","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2003-42642","article-title":"Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East","volume":"23","author":"VC Cheng","year":"2003","journal-title":"Semin Liver Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00535-003-1162-3","article-title":"Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B","volume":"38","author":"WM Ke","year":"2003","journal-title":"J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4049\/jimmunol.0900687","article-title":"Increased killing of liver NK cells by Fas\/Fas ligand and NKG2D\/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure","volume":"184","author":"Y Zou","year":"2010","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2009.127","article-title":"Management of acute liver failure","volume":"6","author":"RT Stravitz","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1566524033479546","article-title":"Mechanisms of human hepatocarcinogenesis","volume":"3","author":"WB Coleman","year":"2003","journal-title":"Curr Mol Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/1566524033479591","article-title":"Mechanisms of viral hepatitis induced liver injury","volume":"3","author":"Y Nakamoto","year":"2003","journal-title":"Curr Mol Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI18114","article-title":"The Fgl2\/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis","volume":"112","author":"PA Marsden","year":"2003","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/hum.2006.17.589","article-title":"Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB\/cJ mice","volume":"17","author":"C Zhu","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2003.12.013","article-title":"Modulation of fibronectin gene expression in inflammatory mononuclear phagocytes of rat liver after acute liver injury","volume":"40","author":"T Armbrust","year":"2004","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.3748\/wjg.v11.i44.6936","article-title":"Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B","volume":"11","author":"CL Zhu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm828","article-title":"RNA interference targeting Fas protects mice from fulminant hepatitis","volume":"9","author":"E Song","year":"2003","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e44138","DOI":"10.1371\/journal.pone.0044138","article-title":"A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis","volume":"7","author":"N Jiang","year":"2012","journal-title":"PLOS ONE"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.20785","article-title":"Adenoviral gene transfer of ABIN-1 protects mice from TNF\/galactosamine-induced acute liver failure and lethality","volume":"42","author":"A Wullaert","year":"2005","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.20872","article-title":"CTLA-4Ig suppresses liver injury by inhibiting acquired immune responses in a mouse model of fulminant hepatitis","volume":"42","author":"Y Nakayama","year":"2005","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"RC Lee","year":"1993","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"DP Bartel","year":"2004","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/156652312803519760","article-title":"In vivo, cardiac-specific knockdown of a target protein, malic enzyme-1, in rat via adenoviral delivery of DNA for non-native miRNA","volume":"12","author":"JM O'Donnell","year":"2012","journal-title":"Curr Gene Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.160.7.3487","article-title":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response","volume":"160","author":"Q Ning","year":"1998","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"DM Morens","year":"2004","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"HB El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1478-3231.2010.02262.x","article-title":"Acute liver failure: mechanisms of immune-mediated liver injury","volume":"30","author":"Z Wu","year":"2010","journal-title":"Liver Int"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1084\/jem.155.5.1464","article-title":"Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase","volume":"155","author":"BS Schwartz","year":"1982","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)64992-9","article-title":"Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis","volume":"156","author":"GA Levy","year":"2000","journal-title":"Am J Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"SK Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"G354","DOI":"10.1152\/ajpgi.2000.278.3.G354","article-title":"Fas and Fas ligand in gut and liver","volume":"278","author":"MJ Pinkoski","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"J Ogasawara","year":"1993","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.182.5.1223","article-title":"Involvement of the CD95 (APO-1\/Fas) receptor and ligand in liver damage","volume":"182","author":"PR Galle","year":"1995","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2893.2002.00338.x","article-title":"Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus","volume":"9","author":"M Rivero","year":"2002","journal-title":"J Viral Hepat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/j.1572-0241.2005.00265.x","article-title":"Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure","volume":"100","author":"A Mita","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/hep.21062","article-title":"Apoptosis and necrosis in the liver: a tale of two deaths?","volume":"43","author":"H Malhi","year":"2006","journal-title":"Hepatology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2000.02268.x","article-title":"Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure","volume":"95","author":"K Ryo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.4049\/jimmunol.153.4.1778","article-title":"Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest","volume":"153","author":"M Leist","year":"1994","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1478-3231.2009.02181.x","article-title":"Acute liver injury upregulates microRNA-491-5p in mice, and its overexpression sensitizes Hep G2 cells for tumour necrosis factor-alpha-induced apoptosis","volume":"30","author":"S Yoon","year":"2010","journal-title":"Liver Int"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"K Pfeffer","year":"1993","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.1994.tb06609.x","article-title":"Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis","volume":"98","author":"KD Sekiyama","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2000.02270.x","article-title":"Significance of soluble TNF receptor-I in acute-type fulminant hepatitis","volume":"95","author":"K Tokushige","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1089\/hum.2009.177","article-title":"Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB\/cJ mice","volume":"21","author":"S Gao","year":"2010","journal-title":"Hum Gene Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"A Fire","year":"1998","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","article-title":"Adenoviruses as gene-delivery vehicles","volume":"334","author":"JM Wilson","year":"1996","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/hum.1993.4.4-403","article-title":"Assessment of recombinant adenoviral vectors for hepatic gene therapy","volume":"4","author":"Q Li","year":"1993","journal-title":"Hum Gene Ther"},{"key":"ref43","first-page":"802","article-title":"Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer","volume":"3","author":"ZS Guo","year":"1996","journal-title":"Gene Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.gt.3300894","article-title":"Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver","volume":"6","author":"S Kuriyama","year":"1999","journal-title":"Gene Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/hum.2010.219","article-title":"Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma","volume":"22","author":"RC Wei","year":"2011","journal-title":"Hum Gene Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1582-4934.2011.01396.x","article-title":"A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect","volume":"16","author":"XR Liu","year":"2012","journal-title":"J Cell Mol Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T12:28:31Z","timestamp":1688819311000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082330"}},"subtitle":[],"editor":[{"given":"Sang Hoon","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}